Hosted on MSN21h
Omvoh Approved for Crohn's; Fitbit Predicts IBD Flares; H. Pylori and Gastric CancerThe FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...
Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...
A 50-year-old woman with a history of Crohn’s disease treated with adalimumab presented with left hand pain and duskiness. Angiogram showed non-filling of the radial and digital arteries of the hand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback